The firm has attorneys in various practice areas and offices in New York, Chicago and San Diego.
NANO X IMAGING STOCK TRIAL
Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. On this news, Nano-X's ordinary share price fell nearly 10%, damaging investors. due within 180 days from the date of the request for additional information." On August 19, 2021, Nano-X reported that Nano-X " received a request for additional information from the concerning the Company's last 510(k) submission of its multi-source device, Nanox.ARC," and that "he submission file is placed on hold pending a complete response to the FDA's list of deficiencies," with "he Company's response. Securities and Exchange Commission filings. Following this submission, defendants touted the Nanox ARC's regulatory and commercial prospects in various public statements and U.S. A 510(k) is a type of premarket submission made to the FDA to demonstrate that a device to be marketed is as safe and effective, that is, substantially equivalent, to a legally marketed device. Food and Drug Administration ("FDA") for its multi-source version of the Nanox.ARC. On June 17, 2021, Nano-X submitted a 510(k) submission to the U.S. Please contact Wolf Haldenstein to learn more about your rights as an investor in Nano-X Imaging Ltd. You may obtain additional information concerning the action or join the case on our website, If you have incurred losses in the shares of Nano-X Imaging Ltd., yo u may, no later than December 6, 2021, request that the Court appoint you lead plaintiff of the proposed class. and incurred losses are u rged to contact the firm immediately at or (800) 575-0735 or (212) 545-4774. (NASDAQ: NNOX) ("Nano-X") securities between Jand Aughas been filed in the United States District Court for the Eastern District of New York.Īll investors who purchased shares of Nano-X Imaging Ltd. 4, 2021 /PRNewswire/ - Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit on behalf of purchasers or acquirers of Nano-X Imaging Ltd. You can opt out at any time.LEAD PLAINTIFF DEADLINE IS DECEMBER 6, 2021
NANO X IMAGING STOCK FREE
As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Fundamental company data provided by Zacks Investment Research. To see all exchange delays and terms of use please see disclaimer. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed.
© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Our Accessibility Statement | Do Not Sell My Information
does not provide financial advice and does not issue recommendations or offers to buy stock or keeps track of all major brokerages’ stock ratings and recommendations, including Goldman Sachs, JPMorgan Chase, Wells Fargo, Bank of America/Merrill Lynch, Citigroup, Morgan Stanley and many more. provides comprehensive coverage of stock ratings, including equities research analysts’ upgrades, downgrades, new coverage and price targetĬhanges. © American Consumer News, LLC dba ® 2010-2021.
0 kommentar(er)
